# OnCo record xynomic-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/xynomic-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "xynomic-pharmaceuticals" ;
  schema:name "Xynomic Pharmaceuticals"@en ;
  schema:alternateName "Xynomic Pharmaceuticals Holdings"@en, "Xynomic Pharma"@en ;
  schema:description "Xynomic Pharmaceuticals is a Chinese-American biotech that licensed the histone deacetylase inhibitor abexinostat from Pharmacyclics and is testing it with pazopanib in kidney cancer and alone in lymphoma."@en ;
  schema:url <https://onco.cc/companies/xynomic-pharmaceuticals/>, <https://www.xynomicpharma.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.xynomicpharma.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "CN" ;
  onco:drugs <https://onco.cc/drugs/abexinostat/> .
